Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_building_white

South Africa halts rollout of AstraZeneca’s COVID-19 vaccine amid efficacy concerns

February 8, 2021
Sales and Marketing AstraZeneca, COVID-19

AstraZeneca is racing to adapt its COVID-19 vaccine as new data suggests it offers little protection against the more dominant …

News
image_readtop_2018_569751_15365546683454581

South Korea approves Celltrion’s COVID-19 treatment Regdanvimab for emergency use

February 8, 2021
Sales and Marketing COVID-19, celltrion

The South Korean Ministry of Food and Drug Safety (MFDS) has granted a conditional marketing authorisation (CMA) for the emergency …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 5, 2021
Medical Communications COVID-19

In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …

News
astrazeneca-sign

New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October

February 5, 2021
Medical Communications AstraZeneca, COVID-19

Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …

News
pfizer_building_logo1

Pfizer withdraws application for emergency vaccine authorisation in India

February 5, 2021
Medical Communications COVID-19, Pfizer

Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …

News
candida_albicans_248_35

Hyloris and Purna Female Healthcare partner to develop novel women’s health product

February 5, 2021
Medical Communications Hyloris, women

Hyloris Pharmaceuticals and Purna Female Healthcare (PFH), a spin-off founded by Purna Pharmaceuticals and Creafund, have entered into a partnership …

News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi misses target in Phase III head and neck cancer trial

February 5, 2021
Medical Communications AstraZeneca, Cancer

AstraZeneca’s Imfinzi (durvalumab) has failed to improve overall survival (OS) for patients with recurrent or metastatic head and neck cancer …

News
mark_wilcox_002

Destiny Pharma appoints Professor Mark Wilcox to its Scientific Advisory Board

February 4, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Destiny Pharma, a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening …

Appointment
scripps_research_web_03-18-19_t670

Scripps Research and IAVI report positive findings from HIV vaccine Phase I trial

February 4, 2021
HIV

Scripps Research and IAVI have returned positive Phase I results in their hunt for a HIV vaccine, detecting a targeted …

News
astrazeneca-sign

China approves AstraZeneca’s heart failure drug Forxiga

February 4, 2021
AstraZeneca, Forxiga

AstraZeneca’s Forxiga (dapagliflozin) has been approved for use in China to reduce the risk of death and hospitalisation from heart …

News
caroline_oconnor

Raremark appoints Caroline O’Connor as CCO

February 4, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark has appointed Caroline O’Connor as its new Chief Commercial Officer. Previously holding the position of Raremark’s Senior Vice President …

Appointment

Pfizer and Imcyse enter research and licence agreement for rheumatoid arthritis programme

February 4, 2021
Imcyse, Pfizer

Imcyse has entered into a research collaboration and licence agreement with Pfizer for Imcyse’s rheumatoid arthritis (RA) programme based on …

News

NICE recommends MSD’s Keytruda in combination with chemotherapy for lung cancer

February 4, 2021
Cancer, MSD

NICE has recommended MSD’s Keytruda (pembrolizumab) with pemetrexed and platinum chemotherapy (pembrolizumab combination) as a first-line option for untreated, metastatic, …

News
jazz_pharma

Jazz acquires GW Pharmaceuticals in $7.2 billion deal

February 4, 2021
cannabinoid, jazz pharmaceuticals

Jazz Pharmaceuticals has acquired GW Pharmaceuticals for over $7 billion, with the transition expected to close in the second quarter …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

February 3, 2021
Research and Development COVID-19

The past week has seen mostly positive COVID-19 vaccine developments; Pfizer has confirmed its jab is effective against both the …

News
astrazeneca_sign_sky

Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says

February 3, 2021
Research and Development AstraZeneca, COVID-19

A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …

News

GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine

February 3, 2021
Research and Development COVID-19, CureVac, GlaxoSmithKline

GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …

News
stock-incyte-01-shutter

CHMP recommends marketing authorisation for Incyte’s pemigatinib

February 3, 2021
Research and Development EMA, Incyte

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the conditional marketing authorisation of Incyte’s pemigatinib for …

News

New urine test could detect womb cancer in three hours

February 3, 2021
Research and Development Cancer, urine test

A simple test using patented technology to detect the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) in urine could …

News
philippe_dro

Scenic Biotech appoints Dr Philippe Dro as Chairman

February 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …

Appointment
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026